In the last trading session, 0.77 million Virpax Pharmaceuticals Inc (NASDAQ:VRPX) shares changed hands as the company’s beta touched 1.10. With the company’s per share price at $0.17 changed hands at $0.0 or 1.50% during last session, the market valuation stood at $4.49M. VRPX’s last price was a discount, traded about -2735.29% off its 52-week high of $4.82. The share price had its 52-week low at $0.16, which suggests the last value was 5.88% up since then. When we look at Virpax Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 1.91 million shares, with the 3-month average coming to 5.49 million.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Instantly VRPX was in green as seen at the end of in last trading. With action -11.01%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -55.51%, with the 5-day performance at -11.01% in the red. However, in the 30-day time frame, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is -41.50% down. Looking at the short shares, we see there were 0.96 million shares sold at short interest cover period of 0.08 days.
The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 94.33% from its current market value. According to analyst projections, VRPX’s forecast low is 3 with 3 as the target high. To hit the forecast high, the stock’s price needs a -1664.71% plunge from its current level, while the stock would need to soar -1664.71% for it to hit the projected low.
The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 14.86%. The 2025 estimates are for Virpax Pharmaceuticals Inc earnings to increase by 78.10%, but the outlook for the next 5-year period is at 66.22% per year.
VRPX Dividends
Virpax Pharmaceuticals Inc is expected to release its next quarterly earnings report on 2025-Mar-02.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.13% of Virpax Pharmaceuticals Inc shares while 0.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.48%. There are 0.47% institutions holding the Virpax Pharmaceuticals Inc stock share, with PARALLEL ADVISORS, LLC the top institutional holder. As of 2024-06-30, the company held 0.0001% of the shares, roughly 1.0 VRPX shares worth $1.0.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund . With 25.31 shares estimated at $4276.0 under it, the former controlled 0.10% of total outstanding shares. On the other hand, Fidelity Total Market Index Fund held about 0.03% of the shares, roughly 8.76 shares worth around $1479.0.
